ACM
CDMO

AlphaCrest Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

AlphaCrest Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,997
Closed -$183K – 1408
2022
Q2 		$183K Buy
+11,997
New +$177K 0.01% 1212

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AlphaCrest Capital Management's CDMO Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 11,997 shares — an estimated $183K sold.

AlphaCrest Capital Management first reported a position in CDMO in Q2 2022 and held it in 1 quarter. The position peaked at $183K in Q2 2022. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 11,997 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $183K.
  • AlphaCrest Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • AlphaCrest Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $183K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.